Flynn James E.

Recent transactions

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

1. Nuvalent, Inc.8,299,225reported24 Nov 2025
   tx 6+ 12,576− 742,574
2. ANTARES PHARMA INC6,807,533reported30 Sept 2015
   tx 15− 1,828,529
3. AdaptHealth Corp.6,045,652reported02 Apr 2018
   tx 5+ 7,666,666− 925,761
4. ARS Pharmaceuticals, Inc.4,887,254reported27 Jun 2025
   tx 2− 740,149
5. ALIMERA SCIENCES INC4,624,284reported03 Dec 2015
   tx 6+ 243,252
6. SALIX PHARMACEUTICALS LTD3,913,471reported30 Dec 2008
   tx 6+ 308,400
7. Hana Biosciences Inc2,974,566reported16 Jul 2013
   tx 72+ 26,969,971− 28,550,400
8. Werewolf Therapeutics, Inc.2,552,787reported04 May 2021
   tx 3+ 2,552,787− 15,195,094
9. CAS MEDICAL SYSTEMS INC2,358,636reported26 Jan 2017
   tx 3− 636,238
10. MEDICINES CO /DE2,325,237reported06 Apr 2011
    tx 24+ 667,040− 436,999